Very low-density lipoprotein receptor (VLDLR)-C-tag purification from HEK293E cells - Aligning Science Across Parkinson's

Research Community
Research Community

ASAP supports three programs and serves as a member of multiple consortia to advance research for the benefit of the global Parkinson’s disease community.
Explore
Highlights
Highlights

ASAP shares the impact that our initiative, network, and supported programs have had on providing new insights into Parkinson’s disease. Discover news, interviews, awards, and annual impact.
Explore
Open Science
Open Science

ASAP is dedicated to facilitating a research environment where meaningful collaboration, research-enabling resources, and data sharing provides the answers we need to understand, diagnose, and treat Parkinson’s disease. Discover our open science philosophy.
Explore
Tools & Resources
Tools & Resources

ASAP is committed to developing and openly sharing research outputs, including data, code, protocols, and key lab materials, to help the scientific community build upon existing work.
Explore

Description

This protocol details how to purify recombinant Very low-density lipoprotein receptor (VLDLR)-C-tag protein from HEK293E cells.

Identifier (DOI)

10.17504/protocols.io.j8nlkoqw1v5r/v1

Tags

Protein purification

Team

Team Harper

Program

Collaborative Research Network

Theme

PD Functional Genomics

Meet the Authors

Andreas Bracher

External Collaborator
Patricia Yuste Checa, PhD

Key Personnel: Team Harper,

Max Planck Institute of Biochemistry
Franz-Ulrich Hartl, MD

Co-PI (Core Leadership): Team Harper,

Max Planck Institute of Biochemistry